{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:56:08Z","timestamp":1775832968739,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008050","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000}}],"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013996","name":"GHIT","doi-asserted-by":"crossref","award":["G2015-211"],"award-info":[{"award-number":["G2015-211"]}],"id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008050","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T18:30:51Z","timestamp":1582914651000},"page":"e0008050","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9944-8937","authenticated-orcid":true,"given":"Seth G","family":"Thacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian L.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Halie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Beaucage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swaksha","family":"Rachuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranadhir","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrokh","family":"Modabber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Bilbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron","family":"Arana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-3071","authenticated-orcid":true,"given":"Daniela","family":"Verthelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"issue":"10151","key":"pntd.0008050.ref001","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"S Burza","year":"2018","journal-title":"The Lancet"},{"issue":"9","key":"pntd.0008050.ref002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"R Reithinger","year":"2007","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"pntd.0008050.ref003","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New World and Old World Leishmania Infections: A Practical Review","volume":"33","author":"I Kevric","year":"2015","journal-title":"Dermatol Clin"},{"issue":"3","key":"pntd.0008050.ref004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and Economic Burden of Human Leishmaniasis","volume":"94","author":"I Okwor","year":"2016","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pntd.0008050.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"pntd.0008050.ref006","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2014current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"SL Croft","year":"2003","journal-title":"Trends Parasitol"},{"issue":"3","key":"pntd.0008050.ref007","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"TR Navin","year":"1992","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0008050.ref008","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1590\/S0036-46652014000400004","article-title":"Factors associated to adherence to different treatment schemes with meglumine antimoniate in a clinical trial for cutaneous leishmaniasis","volume":"56","author":"MN Ribeiro","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"10","key":"pntd.0008050.ref009","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1469-0691.2011.03635.x","article-title":"Leishmaniasis impact and treatment access","volume":"17","author":"M den Boer","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"pntd.0008050.ref010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2007.76.681","article-title":"Characterization of natural antimony resistance in Leishmania donovani isolates","volume":"76","author":"MK Mittal","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pntd.0008050.ref011","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs","volume":"33","author":"A Hefnawy","year":"2017","journal-title":"Trends in Parasitology"},{"issue":"5","key":"pntd.0008050.ref012","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites","volume":"3","author":"R Hadighi","year":"2006","journal-title":"PLoS Med"},{"issue":"8","key":"pntd.0008050.ref013","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","article-title":"American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility?","volume":"194","author":"V Yardley","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"issue":"12","key":"pntd.0008050.ref014","doi-asserted-by":"crossref","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"A Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0008050.ref015","doi-asserted-by":"crossref","first-page":"e0178592","DOI":"10.1371\/journal.pone.0178592","article-title":"Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil","volume":"12","author":"MN Saheki","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0008050.ref016","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0037-86822006000400001","article-title":"An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable","volume":"39","author":"MP de Oliveira-Neto","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"pntd.0008050.ref017","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"D Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"pntd.0008050.ref018","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"P Scott","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"7","key":"pntd.0008050.ref019","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pntd.0000491","article-title":"First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony","volume":"3","author":"C Miranda-Verastegui","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008050.ref020","first-page":"9014726","article-title":"Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review","volume":"2018","author":"TRN Berbert","year":"2018","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"pntd.0008050.ref021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2005.73.79","article-title":"Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials","volume":"73","author":"RP Almeida","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008050.ref022","author":"A Firooz","year":"2007","journal-title":"Imiquimod in Combination With Meglumine Antimoniate for Cutaneous Leishmaniasis"},{"issue":"1","key":"pntd.0008050.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trstmh.2009.07.026","article-title":"Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration","volume":"104","author":"AM Musa","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"pntd.0008050.ref024","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0035-9203(03)90093-9","article-title":"Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990\u201399","volume":"97","author":"J Convit","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"pntd.0008050.ref025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","article-title":"Psoriasis induced by topical imiquimod","volume":"45","author":"JK Wu","year":"2004","journal-title":"Australas J Dermatol"},{"issue":"1","key":"pntd.0008050.ref026","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/AAC.00858-09","article-title":"Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta)","volume":"54","author":"G Grimaldi","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0008050.ref027","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1521-6616(03)00202-X","article-title":"Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates","volume":"109","author":"D Verthelyi","year":"2003","journal-title":"Clin Immunol"},{"issue":"4","key":"pntd.0008050.ref028","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.168.4.1659","article-title":"CpG oligodeoxynucleotides as vaccine adjuvants in primates","volume":"168","author":"D Verthelyi","year":"2002","journal-title":"J Immunol"},{"issue":"8","key":"pntd.0008050.ref029","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.73.8.4948-4954.2005","article-title":"Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D\/A Oligodeoxynucleotides Expressing CpG Motifs","volume":"73","author":"B Flynn","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"pntd.0008050.ref030","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.170.9.4717","article-title":"CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection","volume":"170","author":"D Verthelyi","year":"2003","journal-title":"J Immunol"},{"key":"pntd.0008050.ref031","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.166.4.2372","article-title":"Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs","volume":"166","author":"D Verthelyi","year":"2001","journal-title":"J Immunol"},{"key":"pntd.0008050.ref032","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","article-title":"Identification of CpG oligonucleotide sequences with high induction of IFNa\/b in plasmacytoid dendritic cells","volume":"31","author":"A Krug","year":"2001","journal-title":"Eur J Immunol"},{"issue":"9","key":"pntd.0008050.ref033","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/1521-4141(200209)32:9<2617::AID-IMMU2617>3.0.CO;2-F","article-title":"CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells","volume":"32","author":"M Gursel","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"pntd.0008050.ref034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of Toll-like receptor signals in innate immune defence","volume":"7","author":"G Trinchieri","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"pntd.0008050.ref035","doi-asserted-by":"crossref","first-page":"e15252","DOI":"10.1371\/journal.pone.0015252","article-title":"Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins","volume":"5","author":"D Verthelyi","year":"2010","journal-title":"PLoS One"},{"key":"pntd.0008050.ref036","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1191\/096120301674365881","article-title":"Disassociation of sex hormone levels and cytokine production in SLE patients","volume":"10","author":"D Verthelyi","year":"2001","journal-title":"Lupus"},{"issue":"2","key":"pntd.0008050.ref037","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1532\/IJH97.04116","article-title":"A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma","volume":"81","author":"T Maeda","year":"2005","journal-title":"Int J Hematol"},{"issue":"1","key":"pntd.0008050.ref038","first-page":"159","article-title":"Development of the Morgan Island rhesus monkey colony","volume":"8","author":"DM Taub","year":"1989","journal-title":"P R Health Sci J"},{"issue":"2","key":"pntd.0008050.ref039","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"GF Spath","year":"2001","journal-title":"Exp Parasitol"},{"issue":"22","key":"pntd.0008050.ref040","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1093\/nar\/gkl867","article-title":"Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates","volume":"34","author":"M Puig","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"pntd.0008050.ref041","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.4049\/jimmunol.1203230","article-title":"Human Dendritic Cells Exhibit a Pronounced Type I IFN Signature following Leishmania major Infection That Is Required for IL-12 Induction","volume":"192","author":"MA Favila","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"1","key":"pntd.0008050.ref042","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1074-7613(00)80460-4","article-title":"Type 1 interferon (IFNalpha\/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite","volume":"8","author":"A Diefenbach","year":"1998","journal-title":"Immunity"},{"issue":"4","key":"pntd.0008050.ref043","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbrc.2003.12.041","article-title":"Structural studies of oligonucleotides containing G-quadruplex motifs using AFM","volume":"313","author":"LT Costa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"32","key":"pntd.0008050.ref044","doi-asserted-by":"crossref","first-page":"33071","DOI":"10.1074\/jbc.M311662200","article-title":"Necessity of oligonucleotide aggregation for toll-like receptor 9 activation","volume":"279","author":"CCN Wu","year":"2004","journal-title":"J Biol Chem"},{"issue":"9","key":"pntd.0008050.ref045","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/AAC.44.9.2406-2410.2000","article-title":"Sodium Stibogluconate (Pentostam) Potentiates Oxidant Production in Murine Visceral Leishmaniasis and in Human Blood","volume":"44","author":"S Rais","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"pntd.0008050.ref046","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/AAC.27.6.916","article-title":"Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate","volume":"27","author":"JD Berman","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pntd.0008050.ref047","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.18632\/oncotarget.563","article-title":"Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects","volume":"2","author":"T Yi","year":"2011","journal-title":"Oncotarget"},{"issue":"1","key":"pntd.0008050.ref048","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0035-9203(88)90267-2","article-title":"Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate","volume":"82","author":"JD Chulay","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"pntd.0008050.ref049","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/15287394.2012.624826","article-title":"Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate","volume":"75","author":"K Friedrich","year":"2012","journal-title":"J Toxicol Environ Health A"},{"issue":"2","key":"pntd.0008050.ref050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40262-017-0570-0","volume":"57","author":"AE Kip","year":"2018","journal-title":"Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs"},{"issue":"2","key":"pntd.0008050.ref051","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nm.4023","article-title":"Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites","volume":"22","author":"F Dotiwala","year":"2016","journal-title":"Nat Med"},{"issue":"4","key":"pntd.0008050.ref052","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s12639-014-0641-1","article-title":"Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial","volume":"40","author":"S Farajzadeh","year":"2016","journal-title":"J Parasit Dis"},{"issue":"1","key":"pntd.0008050.ref053","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"W Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"pntd.0008050.ref054","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial","volume":"41","author":"J Machado-Pinto","year":"2002","journal-title":"Int J Dermatol"},{"key":"pntd.0008050.ref055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4061\/2011\/571242","article-title":"Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions","volume":"2011","author":"AK Haldar","year":"2011","journal-title":"Mol Biol Int"},{"issue":"6","key":"pntd.0008050.ref056","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14712598.4.6.937","article-title":"Use of CpG oligodeoxynucleotides as immunoprotective agents","volume":"4","author":"DM Klinman","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"1A","key":"pntd.0008050.ref057","first-page":"56","article-title":"The revival of CpG oligonucleotide-based cancer immunotherapies","volume":"22","author":"T Adamus","year":"2018","journal-title":"Contemp Oncol (Pozn)"},{"issue":"6","key":"pntd.0008050.ref058","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"AM Krieg","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"pntd.0008050.ref059","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1073\/pnas.87.3.867","article-title":"G-DNA: A Twice-Folded DNA Structure Adopted by Single-Stranded Oligo(dG) and Its Implications for Telomeres","volume":"87","author":"IG Panyutin","year":"1990","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"pntd.0008050.ref060","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/2159-8290.CD-18-0280","article-title":"SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study","volume":"8","author":"A Ribas","year":"2018","journal-title":"Cancer Discov"},{"issue":"11","key":"pntd.0008050.ref061","doi-asserted-by":"crossref","first-page":"e48727","DOI":"10.1371\/journal.pone.0048727","article-title":"CXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells","volume":"7","author":"S Majumder","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0008050.ref062","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.20061293","article-title":"NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs","volume":"204","author":"U Schleicher","year":"2007","journal-title":"J Exp Med"},{"issue":"2","key":"pntd.0008050.ref063","doi-asserted-by":"crossref","first-page":"e1006196","DOI":"10.1371\/journal.ppat.1006196","article-title":"CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1\u03b2 production","volume":"13","author":"FO Novais","year":"2017","journal-title":"PLoS Pathog"},{"issue":"11","key":"pntd.0008050.ref064","doi-asserted-by":"crossref","first-page":"e112410","DOI":"10.1371\/journal.pone.0112410","article-title":"NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines","volume":"9","author":"IC Caneda-Guzman","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0008050.ref065","doi-asserted-by":"crossref","first-page":"e94596","DOI":"10.1371\/journal.pone.0094596","article-title":"Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis","volume":"9","author":"R Shivahare","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"pntd.0008050.ref066","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran","volume":"81","author":"A Asilian","year":"2003","journal-title":"Bull World Health Organ"},{"key":"pntd.0008050.ref067","doi-asserted-by":"crossref","first-page":"571242","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"AK Haldar","year":"2011","journal-title":"Mol Biol Int"},{"issue":"5","key":"pntd.0008050.ref068","doi-asserted-by":"crossref","first-page":"e2875","DOI":"10.1371\/journal.pntd.0002875","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia","volume":"8","author":"E Diro","year":"2014","journal-title":"PLoS Negl Trop Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008050","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T16:08:11Z","timestamp":1614614891000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008050"}},"subtitle":[],"editor":[{"given":"Abhay R.","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008050","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008050","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]}}}